|  | All |
---|---|---|
Variable | Â | Median (IQR) |
Age | years | 67 (59-75) |
Male gender | n (%) | 101 (55%) |
Disease severity | Â | Â |
Lactate | mmol/l | 2.2 (1.4-3.7) |
SBP | mmHg | 82 (70-92) |
SOFA | score | 8 (6-10) |
SAPS | score | 56 (41-68) |
Biochemistry | Â | Â |
Hemoglobin | g/dl | 9.5 (8.4-10.8) |
White blood cells | 109/l | 12.3 (7.4-20.1) |
Platelet count | 109/l | 133 (71-232) |
Creatinine | μmol/l | 97 (62-172) |
BUN | μmol/l | 10.5 (6.8-17.7) |
Bilirubin | μmol/l | 12 (7-21) |
D-dimer | mg FEU/l | 4.8 (2.2-9.6) |
Owren type PT | % | 0.47 (0.34-0.61) |
Plasma fibrinogen | g/l | 4.7 (3.4-6.5) |
Endothelial biomarkers | Â | Â |
Syndecan-1 | ng/ml | 97 (51-204) |
Thrombomodulin | ng/ml | 7.7 (5.2-10.8) |
Protein C | % | 47.4 (33.5-66.4) |
tPA | ng/ml | 16.4 (11.4-23.6) |
PAI | ng/ml | 30.9 (19.3-39.5) |
Thrombelastography (TEG) | Â | Â |
R-time | min | 7.7 (6.4-9.3) |
Angle | degrees | 65 (55-71) |
TEG MA | mm | 66 (58-72) |
Ly30 | % | 0 (0.0-0.3) |
Ly30 > 0% | n (%) | 65 (36%) |
Functional fibrinogen (FF) | Â | Â |
FF MA | mm | 21.9 (16.1-28.8) |
Transfusions in ICU | Â | Â |
RBC | n (%) | 119 (65%) |
FFP | n (%) | 64 (35%) |
Platelets | n (%) | 52 (28%) |
Mortality | Â | Â |
7-day | n (%) | 39 (21%) |
28-day | n (%) | 72 (39%) |
90-day | n (%) | 98 (53%) |
1-year | n (%) | 113 (61%) |